Literature DB >> 11483230

Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes.

K Hiragushi1, H Sugimoto, K Shikata, T Yamashita, N Miyatake, Y Shikata, J Wada, I Kumagai, M Fukushima, H Makino.   

Abstract

Glomerular hyperfiltration plays a pathogenic role in the early stages of diabetic nephropathy. Experimental studies in laboratory animals suggest that nitric oxide (NO) might be involved in the pathogenesis of glomerular hyperfiltration. We performed a cross-sectional study to determine the relationship between diabetic glomerular hyperfiltration and the NO system. Normoalbuminuric (n=41), microalbuminuric (n=25), and macroalbuminuric (n=16) patients with type 2 diabetes were recruited in this study and compared with age-matched 84 non-diabetic control subjects. Creatinine clearance and urinary NO(2)(-)/NO(3)(-) excretion (urinary NOx) were measured, and the expression of endothelial cell nitric oxide synthase (ecNOS) was evaluated in human renal tissues. Glomerular hyperfiltration was present in 19 (37.5%) and nine (36.6%) of normoalbuminuric and microalbuminuric type 2 diabetic patients, respectively. The urinary NOx was significantly higher in normoalbuminuric patients compared with normal subjects. Creatinine clearance correlated significantly with urinary NOx in normoalbuminuric and microalbuminuric patients. Immunohistochemical staining intensities for ecNOS were significantly increased in glomerular endothelial cells of microalbuminuric type 2 diabetic patients as compared with the control subjects. These results suggest that NO may contribute to the pathogenesis of glomerular hyperfiltration in Japanese type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483230     DOI: 10.1016/s0168-8227(01)00260-1

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  17 in total

1.  Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients.

Authors:  Atsuhito Tone; Kenichi Shikata; Koichi Nakagawa; Masaaki Hashimoto; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

Review 2.  Pathogenic role of nitric oxide alterations in diabetic nephropathy.

Authors:  Sharma S Prabhakar
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

3.  Renal hyperfiltration related to diabetes mellitus and obesity in human disease.

Authors:  Alexa N Sasson; David Zi Cherney
Journal:  World J Diabetes       Date:  2012-01-15

4.  Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.

Authors:  A Tone; K Shikata; M Sasaki; S Ohga; K Yozai; S Nishishita; H Usui; R Nagase; D Ogawa; S Okada; Y Shikata; J Wada; H Makino
Journal:  Diabetologia       Date:  2005-10-18       Impact factor: 10.122

5.  NOx (nitrite/nitrate) in patients with pediatric nephrotic syndrome.

Authors:  Hisashi Kawashima; Yasuyo Kashiwagi; Chiako Watanabe; Satoshi Sato; Shigeo Nishimata; Kouji Takekuma; Akinori Hoshika; Yasuo Watanabe
Journal:  Pediatr Nephrol       Date:  2007-02-08       Impact factor: 3.714

6.  Antioxidant diet and sex interact to regulate NOS isoform expression and glomerular mesangium proliferation in Zucker diabetic rat kidney.

Authors:  Yuriy Slyvka; Ramiro Malgor; Sharon R Inman; Julia Ding; Victor Heh; Felicia V Nowak
Journal:  Acta Histochem       Date:  2016-01-18       Impact factor: 2.479

Review 7.  Role of glomerular filtration rate in controlling blood pressure early in diabetes.

Authors:  Michael W Brands; Hicham Labazi
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

8.  Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.

Authors:  Tracy D Bell; Gerald F DiBona; Rachel Biemiller; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

9.  Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.

Authors:  David Z I Cherney; Heather N Reich; Shan Jiang; Ronnie Har; Rania Nasrallah; Richard L Hébert; Vesta Lai; James W Scholey; Etienne B Sochett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-01       Impact factor: 3.619

10.  Risk of proteinuria among individuals with persistent borderline diabetes: the Saku study.

Authors:  Yukako Tatsumi; Akiko Morimoto; Fumie Soyano; Tetsuo Shimoda; Naomi Miyamatsu; Yuko Ohno; Shiro Sakaguchi
Journal:  Diabetol Int       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.